21867-64-1

Basic information

• Product Name: 1-PROPYLPIPERAZINE
• Synonyms: TIMTEC-BB SBB005871;N-PROPYL PIPERAZINE;1-N-PROPYLPIPERAZINE;1-PROPYLPIPERAZINE;AKOS BBS-00003600;zhengzhou Pacific CheMSource, Inc.;N-n-Propyl piperazine 1-n-Propylpiperazine;N-n-Propyl piperazine
• CAS NO: 21867-64-1
• Molecular Formula: C₇H₁₆N₂
• Molecular Weight: 128.22
• EINECS: 256-745-9
• Mol File: 21867-64-1.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 176.7 °C at 760 mmHg
• Flash Point: 60.7 °C
• Appearance: /
• Density: 0.868 g/cm³
• Vapor Pressure: 1.08mmHg at 25°C
• Refractive Index: 1.445
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• CAS DataBase Reference: 1-PROPYLPIPERAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-PROPYLPIPERAZINE(21867-64-1)
• EPA Substance Registry System: 1-PROPYLPIPERAZINE(21867-64-1)

Safety Data

• Hazardous Substances Data: 21867-64-1(Hazardous Substances Data)

Usage

General Description

1-Propylpiperazine is a chemical compound with the molecular formula C8H18N2. It is a colorless liquid with a faint odor that is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 1-Propylpiperazine is also used as a corrosion inhibitor in metalworking fluids and as a precursor for the production of specialty chemicals. It is considered to be a moderately hazardous chemical with potential health risks if ingested or inhaled, and should be handled with proper safety precautions. 1-Propylpiperazine is not known to be naturally occurring and is typically produced through chemical synthesis processes.

InChI:InChI=1/C7H16N2/c1-2-5-9-6-3-8-4-7-9/h8H,2-7H2,1H3

Upstream product

• 120-43-4 4-ethoxycarbonylpiperazine 

Downstream Products

• 957438-19-6 C₂₅H₃₆N₆O 
• 24637-28-3 <4-Propyl-piperazino>-essigsaeure-aethylester 
• 308087-17-4 N-acryloyl-N'-propyl piperazine 
• 736910-19-3 Acetic acid 4-(4-propyl-piperazine-1-carbonyl)-phenyl ester 
• 77166-28-0 N-(2-Allyloxy-phenyl)-N-[2-hydroxy-3-(4-propyl-piperazin-1-yl)-propyl]-4-methoxy-benzenesulfonamide; hydrochloride 
• 77166-13-3 N-(2-Allyloxy-phenyl)-N-[2-hydroxy-3-(4-propyl-piperazin-1-yl)-propyl]-4-methyl-benzenesulfonamide; hydrochloride 
• 77176-47-7 N-(2-Allyloxy-phenyl)-N-[2-hydroxy-3-(4-propyl-piperazin-1-yl)-propyl]-methanesulfonamide; hydrochloride 
• 124255-93-2 8-Fluoro-3-methyl-6-oxo-9-(4-propyl-piperazin-1-yl)-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid 
• 150208-58-5 1-<(3,4-dichlorophenyl)acetyl>-4-(1-propyl)piperazine 
• 56915-94-7 2-oxo-6-[4-(4-propyl-piperazin-1-yl)-phenyl]-1,2-dihydro-pyridine-3-carbonitrile 

Relevant articles and documents

2-,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use

The present invention provides substituted dibenzoxazepine and dibenzthiazepine compounds of Formula I: STR1 which are useful as analgesic agents for the treatment of pain, and for prostaglandin-E2 mediated diseases, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal, and a method for treating prostaglandin-E2 mediated diseases in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.